nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
|
D’Alterio, C. |
|
|
74 |
6 |
|
artikel |
2 |
Blockade of TIGAR prevents CD8+ T cell dysfunction and elicits anti-AML immunity
|
Cui, Jialin |
|
|
74 |
6 |
|
artikel |
3 |
Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study
|
Wang, Yilin |
|
|
74 |
6 |
|
artikel |
4 |
Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer
|
Deng, Jia-Yi |
|
|
74 |
6 |
|
artikel |
5 |
Combination of immune checkpoint inhibitors and anthracyclines as a potential first-line regimen for dedifferentiated liposarcoma: systematic review and meta-analysis
|
Aobo, Zhuang |
|
|
74 |
6 |
|
artikel |
6 |
Correction: Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer
|
Tak, Eunyoung |
|
|
74 |
6 |
|
artikel |
7 |
Correction: Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer
|
Tan, Yang |
|
|
74 |
6 |
|
artikel |
8 |
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma
|
Berclaz, Luc M. |
|
|
74 |
6 |
|
artikel |
9 |
Dynamics of tertiary lymphoid structures and immune cross talk in early versus advanced colorectal cancer: potential implications for immunotherapy
|
Chen, Zixu |
|
|
74 |
6 |
|
artikel |
10 |
Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells
|
Brauneck, Elias |
|
|
74 |
6 |
|
artikel |
11 |
GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout
|
Jünemann, Wiebke |
|
|
74 |
6 |
|
artikel |
12 |
Identification and validation of poor prognosis immunoevasive subtype of esophageal cancer with tumor-infiltrating SAMD3 + NK cell abundance
|
Huang, Xu |
|
|
74 |
6 |
|
artikel |
13 |
Identification of SURF4 and RALGAPA1 as promising therapeutic targets in glioblastoma and pan-cancer through integrative multi-omics, CRISPR-Cas9 screening and prognostic meta-analysis
|
Wang, Fei |
|
|
74 |
6 |
|
artikel |
14 |
In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression
|
Xu, Yan |
|
|
74 |
6 |
|
artikel |
15 |
Multifaceted functions of tissue-resident memory T cells in tumorigenesis and cancer immunotherapy
|
Seo, Eun Sang |
|
|
74 |
6 |
|
artikel |
16 |
Prognostic nutrition index reveals LAG3 in cytotoxic CD8+ T cells and MHC class II in gastric cancer cells
|
Tsutsumi, Chikanori |
|
|
74 |
6 |
|
artikel |
17 |
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis
|
Villar, Sara |
|
|
74 |
6 |
|
artikel |
18 |
Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemia
|
Li, Weiwang |
|
|
74 |
6 |
|
artikel |
19 |
Transcriptomic and proteomic characterization of cell and protein biomarkers of checkpoint inhibitor-induced liver injury
|
Ji, Changhua |
|
|
74 |
6 |
|
artikel |
20 |
USP5 motivates immunosuppressive microenvironment in multiple myeloma by activating STAT2-PFKFB4-mediated glycolysis
|
Long, Shifeng |
|
|
74 |
6 |
|
artikel |